Compound Weight Loss Drugs Restriction
- The availability of compounded versions of popular weight loss drugs, including Wegovy and Zepbound, faces uncertainty.
- Compounded drugs are essentially copies of medications approved by the U.S.
- Drug compounding is typically permitted when drugs are on the FDAS shortage list or when a patient requires an choice because they cannot tolerate a version of a...
The Future of GLP-1 Drugs: Availability and Cost-Saving Options
Table of Contents
The availability of compounded versions of popular weight loss drugs, including Wegovy and Zepbound, faces uncertainty. This comes after a U.S. judge declined an initial injunction that would have allowed compounding pharmacies to continue producing these versions.
Compounded drugs are essentially copies of medications approved by the U.S. Food and Drug Administration (FDA).While licensed pharmacies make them, they do not undergo the same rigorous approval or inspection processes as FDA-approved drugs.
Drug compounding is typically permitted when drugs are on the FDAS shortage list or when a patient requires an choice because they cannot tolerate a version of a drug manufactured by a pharmaceutical company.
Recently, both Eli Lilly, the manufacturer of Zepbound and Mounjaro, and Novo Nordisk, the manufacturer of Ozempic and Wegovy, have stated that they can now meet the demand for these medications. This follows shortages experienced since 2022, driven by the increasing popularity of these drugs.
The FDA has acknowledged that these shortages are “resolved,” leading to the removal of these drugs from its shortage list.
Cost Savings on GLP-1 Medications
GLP-1 medications can be expensive, frequently enough costing upwards of $1,000 per month without insurance coverage. However, there are strategies to potentially lower these costs.
If insurance coverage isn’t an option, individuals can explore coupons available on drug manufacturers’ websites.
Eli Lilly and Novo Nordisk now also offer consumers without insurance the opportunity to purchase Zepbound and Wegovy, respectively, through direct-to-consumer platforms at reduced prices.
FDA’s Stance on Compounded GLP-1 Drugs
The FDA has issued warnings regarding the use of compounded versions of FDA-approved medications.
Compounded drugs pose a higher risk to patient than FDA-approved drugs because compounded drugs do not undergo FDA premarket review for safety, effectiveness, or quality.
The agency said in a statement to ABC News in 2023.
The FDA’s goal is to protect patients from substandard compounded drugs while ensuring access to lawfully marketed compounded drugs when necessary.
Compounded versions of drugs, which are customized for individual patients using raw ingredients, are exempt from the FDA’s stringent approval process.
Differences Between Weight Loss Medications
Zepbound has received FDA approval as a weight loss management treatment for individuals with obesity or those who are overweight with at least one weight-related condition, such as high blood pressure.
Zepbound and Mounjaro, both manufactured by Lilly, share the same active ingredient, tirzepatide.While Mounjaro is FDA-approved for treating Type 2 diabetes, some doctors prescribe it “off-label” for weight loss, which is permissible by the FDA.
Tirzepatide enhances insulin production in the pancreas, facilitating the movement of sugar from the blood into body tissues. It also slows gastric emptying and suppresses appetite, leading to weight loss.
Ozempic is FDA-approved for treating Type 2 diabetes, but it is also prescribed “off-label” for weight loss.
wegovy contains semaglutide,the same active ingredient as Ozempic,and is FDA-approved for weight loss in individuals with obesity or who are overweight with at least one weight-related condition. It is also approved to reduce the risk of major cardiovascular events in adults with obesity or who are overweight with established cardiovascular disease.
Semaglutide functions similarly by slowing gastric emptying and curbing appetite, resulting in weight loss.
The Future of GLP-1 Drugs: Availability and Cost-Saving Options – Q&A
Understanding GLP-1 Drugs and Compounding
What are GLP-1 drugs, and what are they used for?
GLP-1 (glucagon-like peptide-1) drugs are a class of medications primarily used for treating Type 2 diabetes and, in some cases, for weight loss. These drugs mimic the effects of the GLP-1 hormone, which helps to regulate blood sugar levels, slow down gastric emptying, and reduce appetite. The most popular medications in